|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/165 | |
| A61K 38/21 | |||
| A61P 25/00 |
| (11) | Number of the document | 2451449 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10731897.4 |
| Date of filing the European patent application | 2010-07-08 | |
| (97) | Date of publication of the European application | 2012-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/041274 |
| Date | 2010-07-08 |
| (87) | Number | WO 2011/005907 |
| Date | 2011-01-13 |
| (30) | Number | Date | Country code |
| 09305669 | 2009-07-10 | EP | |
| 225342 P | 2009-07-14 | US | |
| 286148 P | 2009-12-14 | US | |
| 350957 P | 2010-06-03 | US |
| (72) |
BYRNES, William, US
DOUILLET, Patrice, FR
FRANGIN, Gerald, FR
|
| (73) |
Sanofi-Aventis U.S. LLC,
55 Corporate Drive, Bridgewater, NJ 08807,
US
|
| (54) | USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS |
| USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS |